Laurion Capital Management LP - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$2,131,060
-37.4%
83,9000.0%0.02%
-6.2%
Q4 2022$3,402,984
+22.5%
83,900
-0.2%
0.02%0.0%
Q3 2022$2,779,000
-7.3%
84,095
-1.2%
0.02%
-65.2%
Q2 2022$2,997,000
+68.8%
85,128
+204.1%
0.05%
+228.6%
Q4 2019$1,776,000
+145.6%
27,998
-72.1%
0.01%
+133.3%
Q1 2018$723,000100,2810.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders